COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease

Completed · Not applicable

Conditions studied: Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy

In brief

The goal of this clinical trial is to test an COVID-19 vaccination information video in adults with sickle cell disease. The main questions it aims to answer are why are some adults with sickle cell disease hesitant to receive COVID-19 vaccination and whether a COVID-19 vaccination information video tailored for people with sickle cell disease will reduce vaccine hesitancy. Participants will complete a brief survey before and after watching a short video with information on vaccine safety, efficacy, and the greater impact of COVID-19 infection on people with sickle cell disease.

Key facts

Study ID

NCT05998824

Run by

Duke University

People needed

33

Starts

2023-09-19

Expected to finish

2024-09-30

Last updated by the study team

2024-12-24

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of sickle cell disease

You may not qualify if…

• unable to read or understand spoken English to complete the survey

Where it is running

• Duke Adult Sickle Cell Program — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.